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We applied the machine learning procedure to the analysis of se-
rum and aqueous humor albumin, IgG and interferon- patterns.
The data were analyzed with respect to the cataract, type of diabe-
tes, retinopathy and blood-aqueous humor barrier damage. Intra-
ocular production of IgG was detected in diabetic patients, since
the IgG index values were increased in some diabetic groups (espe-
cially those with type I diabetes and retinopathy). Comparison of
numerical methods and clonal IgG detection suggested that intra-
ocular IgG patterns in diabetes are predominately polyclonal. In-
terferon- (IFN-) was pathological in serum and aqueous humor of
patients with type I diabetes and to a lesser extent in the type II
diabetes group. Machine learning system based on C5.0 classifier
extracted 98.5% accurate rules for discrimination of the senile cat-
aract group, diabetes group and diabetic retinopathy group. Our
results confirm that the combination of immunochemical and nu-
merical methods with a proper statistical analysis may contribute
to the diagnosis of the pathologic ocular immune response and the
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related retinal or vascular disorders in diabetes. Significant sav-
ings in laboratory material and efforts may be obtained by means
of the machine learning based optimization of the tests.
Key words: diabetes, retinopathy, cataract, machine learning, C5.0,
interferon-, aqueous humor, serum, IgG, prognosis, barrier.
INTRODUCTION
Immunochemical information of different immunochemical tests strong-
ly depends on the validity of the procedure, sample preparation and data
analysis. Improvement of sensitivity, specificity and accuracy of enzyme-
immunoassays, and the procedure of freezing and storage of body fluid sam-
ples at low temperatures have directed more attention to the data mining
methods in biomedical analyses of proteins. New computer softwares enable
easy and accurate application of different statistical tools that extract the
links between the measured tests and complex biological systems influenc-
ing their results.
The aim of this study is to perform an immunochemical analysis of pro-
teins in two body fluids and combine it with the new machine learning pro-
cedure based on artificial intelligence. The specific problem that we address
is to classify serum and aqueous humor protein patterns obtained by means
of the immunochemical tests into groups of control, diabetic and retinopathy
samples in cataract, paying heed to the blood-aqueous humor barrier func-
tion.
In uveitis, diabetes and complicated cataracts, the protein pattern of
aqueous humor is often changed because of the barrier leakage, accumula-
tion of inflammatory cells and local intraocular cytokine and immunoglobu-
lin production.1–8 Intraocular protein changes can be evaluated by means of
immunochemical or electrophoretic aqueous humor analyses and calculation
of relative concentration aqueous/serum ratios, i.e. indexes.1–8
Leakage of the blood-aqueous barrier and changes in the aqueous humor
protein patterns have been observed in some cases of diabetic retinopathy.7
Diabetes mellitus of type I is thought to be an autoimmune reaction to the
pancreas -cells, where the local and systemic immunological reaction de-
pends on the IL-2 and interferon- (IFN-).9–11 Similarly to type I diabetes,
the autoantibodies in the type II disease are of the IgG class, against insulin
receptors.11–12
Preretinal membranes of the diabetics are characterized by different pa-
thologic changes, including aggregation of inflammatory cells and increased
discharge of IL-2, IL-4 and IFN-.13–15 Local and systemic presence of the
antiretinal antibodies of the IgG class has also been established.14–16 The
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mentioned laboratory and clinical findings are more prominent in the type I
diabetes.17,18
Therefore, in this study we investigated the serum and aqueous humor
patterns of IFN- and IgG in type I and II diabetes with and without re-
tinopathy. The results of the immunochemical tests were compared to the
senile cataract controls since they do not exhibit any local or systemic pa-
thologic immune response, with respect to the analyzed protein fractions.1–8
In addition to the standard statistical procedure of immunochemical param-
eter analysis, we applied the new C5.0 machine learning system to define
the links between different tests and groups.19 The method of decision tree
and rules estimation for different parameters (tests) has been recently re-
ported to be useful procedure in immunochemical data analysis.20
MATERIALS AND METHODS
Immunochemical Parameters Determination
Albumin and IgG in serum were evaluated on Partigen plates for the standard
single radial immunodiffusion technique (Behring, Marburg, Germany). Aqueous hu-
mor concentrations of albumin and IgG were determined with LC-Partigen plates
for low protein concentration measurements (Behring, Marburg, Germany).1,2,4,6–8
Intraocular IgG synthesis was evaluated by means of the IgG index, calculated
with the following formula: 2–4,6–8
IgG AH index = (AH/S)IgG  (S/AH)albumin
Oligoclonal IgG were detected in diluted serum (1:500) and unconcentrated
aqueous humor by isoelectric focusing of proteins in ultrathin polyacrylamide gel
(0.4 mm), followed by direct immunofixation with monospecific IgG antisera and sil-
ver nitrate staining.4,6–8 Samples with aqueous humor oligoclonal IgG without
matched serum bands were considered positive.4,6–8
IFN- in aqueous humor and serum was analyzed using the quantitative enzyme
immunoassay test kit Immunotech (Marseille, France). The assay is specific for
both natural IFN- and recombinant human IFN-, and demonstrates no cross-reac-
tivity to other interferons. The procedure was performed according to the manufac-
turer’s instructions. Briefly, in the first incubation, IFN- from 50 L of pippeted se-
rum or aqueous samples was bound with primary monoclonal anti-IFN- Ab of the
wells into Ab/Ag immunocomplex. Then, 0.050 mL of the secondary antibody was ad-
ded into each well, followed by 100 L/well of streptavidine bound to horse-radish
peroxidase. After 30 minutes of this secondary reaction in which the secondary anti-
body bound to primary complex and HRP-streptavidine binds to biotine, 100 L/well
of tetramethylbenzidine was added to activate peroxidase. The intensity of colour,
proportional to IFN-g concentration, was measured spectrophotometrically at 450 nm.
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Sample Collection
Aqueous humor (AH) samples were collected at the time of cataract surgery ac-
cording to the procedure described by Zirm1 and Grabner et al.,2 taking account of
the recommendations of Tripathi et al.21 During the collection every precaution was
taken to avoid contact with corneal endothelium, iris or lens.4 100–200 L of each
aqueous sample was collected. The material was stored at –70 °C and analyzed later.
Serum samples were obtained by standard venepunction and stored at –70 °C. While
conducting the investigation, the principles of the Helsinki Declaration were observ-
ed and informed consent was obtained from the subjects.
The control group consistsed of 23 patients with senile uncomplicated cataract
without diabetes, retinopathy and other systemic diseases that could influence their
immunological status. Fifteen of the patients were males (M) and eight were females
(F). The mean age of the group was 67.7 years and the mean cataract duration was
2.2 years.
Type I diabetes group had 22 patients (11 M, 11 F; 9 without, 13 with retino-
pathy), and the type II diabetes group had 23 patients with diabetic cataract (11 M,
12 F; 11 without, 12 with retinopathy). The mean age (type I 69.4 years, type II 71.2)
and cataract duration (type I 2.3 years, type II 2.6) were not statistically different
from the control group. Patients with retinopathy had suffered from diabetes longer
than the ones without retinopathy (p < 0.05).
C5.0 Machine Learning Pogram
The C5.0 program is a commercially available successor to the landmark C4.5
decision tree program.19 C5.0 decision tree induction is essentially the same as in
C4.5, while the tests show some differences but negligible improvements. However,
the C5.0 rule generation has been greatly speeded up compared to C4.5.19
C5.0 and C4.5 define the possible decision tree by means of a hill-climbing
search based on the statistical property measure called information gain.19,20,22 In-
formation gain measure defines how well a given attribute separates the training ex-
amples according to their target classification, and selects candidate attributes at
each step of the tree.19,20,22 Consequently, this measure is the expected reduction in
Shannon’s entropy caused by partitioning the examples according to the attribute in
classifying the training data.19,20,22
The elements of the decision tree are either leaves or decision nodes.19,20,22 The
leaf shows a class and the decision node specifies the test to be implemented on an
attribute value, with one branch and subtree for each possible result of the
test.19,20,22 The starting node is the root node and a tree is used to predict a case by
starting at the root and moving through the tree until the leaf is encountered.20,22
For any tree, all paths lead to a leaf corresponding to a decision rule that is a logical
conjunction of various tests.19,22 If there are multiple paths for a given class, then
the paths represent logical disjunctions.19,20,22 All paths are mutually exclusive. For
any new case, one and only one path in the tree will always have to be satisfied.
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Statistical Analysis
Software STATISTICA, version 5.0, was used for data analysis. The values of
the IgG index, serum and aqueous humor IgG and albumin were compared by means
of two-sided t-test with the correction according Cochran & Cox. IFN- values and
ologoclonal IgG bands in serum and aqueous human were compared by means of the
Fisher exact probability test.
RESULTS
Protein Patterns in Control Samples
IgG index in senile cataract controls was 0.49  0.11, i.e. within the nor-
mal range typical of aqueous humor IgG measurements. Total albumin and
IgG values in serum and aqueous humor were also within the normal range
(Table I). Oligoclonal IgG bands were negative in all samples. Aqueous hu-
mor levels of IFN- in senile cataract controls were below the detection limit
of the test and serum IFN- levels were detectable in only four cases (15.6%,
Table II).
Albumin and IgG in Diabetes and Retinopathy
In the group of patients with type I diabetes without retinopathy a sta-
tistically significant difference (p < 0.05) in aqueous humor albumin was
found compared to the senile cataract controls (Table I). Differences in IgG
indexes among groups were also observed. Group of the type I diabetes pa-
tients with retinopathy differred from the control group, type I diabetes
without retinopathy and type II diabetes with retinopathy (Table I). In type
II diabetes group, the differences were significant only between its retinopa-
thy group and type I retinopathy.
Aqueous humor oligoclonal IgG were found in only 5–10% of the cases in
different diabetic groups; however, the values were not significantly differ-
ent when compared to the senile cataract control group that had no aqueous
IgG bands (p > 0.05).
IFN- in Diabetes and Retinopathy
Pathological aqueous IFN- was found in several groups with diabetic
complications and in none of the senile cateract controls. However, statisti-
cal difference from the senile cataract controls was observed only in type I
diabetes without retinopathy (2 pathological IFN- results out of 9, p < 0.05,
Table II).
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Serum IFN- values in type I diabetes without retinopathy were signifi-
cantly elevated (5 out of 9, p < 0.05). Consequently, the whole type I diabe-
tes group significantly differed from the cataract controls (p < 0.05, Table
II).
Decision Tree and Rule Analysis
C5.0 machine learning system extracted 3 decision trees with the corre-
sponding rules for accurate prediction of the groups of senile cataract con-
trols, diabetes without retinopathy and diabetes with retinopathy. Table III
presents the most accurate tree and rules algorithm (85.3%). Boosting pro-
cedure with 3 trials enables the overall precision of 98.5% for the decision
rules and 91.2% for the decision tree (Table IIIb).
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TABLE I
Albumin and IgG in serum and aqueous humor of patients suffering from senile
cataract, cataract complicated with diabetes without retinopathy (–R), and cata-
ract complicated with diabetes and diabetic retinopathy (+R)
Concentrations
g L–1
Albumin
Serum
Albumin AH
IgG
serum
IgG AH
IgG
index
Senile cataract
XSD
range
39.95.1*
27.5–46.4
0.1670.065
0.061–0.290
12.32.7
8.1–19.9
0.0240.015
0.000–0.051
0.4900.110†
0.264–0.679
Type I
diabetes –R
XSD
range
41.92.1*
38.3–45.4
0.2750.233
0.072–0.758
12.54.7
7.4–22.3
0.0310.021
0.000–0.070
0.4530.195§
0.242–0.873
Type I
diabetes +R
XSD
range
42.12.2
39.3–47.2
0.1800.091
0.056–0.370
13.43.2
8.6–20.9
0.0340.013
0.000–0.049
0.6780.210§†‡
0.377–1.032
Type II
diabetes –R
XSD
range
41.92.2
38.4–44.3
0.1940.128
0.043–0.398
11.92.1
9.8–17.3
0.0230.017
0.000–0.053
0.5250.123
0.347–0.713
Type II
diabetes +R
XSD
range
41.92.7
36.7–45.8
0.2330.149
0.066–0.611
12.82.5
8.4–17.8
0.0310.020
0.000–0.069
0.4500.131‡
0.233–0.668
*p < 0.03; §p < 0.05; †p < 0.01; ‡p < 0.01.
DISCUSSION
Systemic and intraocular aberrations of protein patterns reflect the
changes of cellular and humoral immune response in both types of diabe-
tes.9–18 Our results of IFN- and IgG in serum and aqueous humor confirm
the latter (Table I and Table II).
Albumin is a protein that is not synthesized intraocularly.1–8 Therefore,
it often serves as a marker of protein transfer through blood-ocular barri-
ers.1–8 We found no differences in the aqueous humor albumin concentration
between groups. Similar applies to aqueous/serum albumin concentration
ratio, which suggested that protein transfer through the blood-aqueous bar-
rier was not significantly impaired in diabetes and retinopathy.1–4,6,8
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TABLE II
Serum and aqueous humor values of interferon- in patients suffering from senile
cataract, cataract complicated with diabetes without retinopathy (–R), and cata-
ract complicated with diabetes and diabetic retinopathy (+R)
Concentrations in IU mL–1 IFN- Serum IFN- AH
Senile cataract
XSD
range
0.2100.470*
0.000–1.490
0.000**
0.000
Type I diabetes –R
XSD
range
No.  (>2SD)
1.3461.526*
0.000–3.690
5
0.1640.394**
0.000–1.180
2
Type I diabetes +R
XSD
range
No.  (>2SD)
0.6211.307
0.000–4.250
3
0.0050.017
0.000–0.006
1
Type II diabetes –R
XSD
range
No.  (>2SD)
0.4020.931
0.000–2.790
2
0.000
0.000
0
Type II diabetes +R
XSD
range
No.  (>2SD)
0.2410.834
0.000–2.890
1
0.0020.006
0.000–0.020
1
*p < 0.05; **p < 0.05.
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TABLE III (a–c)
C5.0 decision tree and rule analysis of immunochemical parameters in patients
suffering from senile cataract (C), cataract complicated with diabetes without retinopathy
(D), and cataract complicated with diabetes and diabetic retinopathy (R)
a. Options:
Generating rules
Rule utility ordering (1/5’s)
Boost using 3 trials
Fuzzy thresholds
Class specified by attribute `diagnosis’
C = Senile cataract control;
D = Diabetes without retinopathy;
R = Diabetes with retinopathy.
Read 68 cases (10 attributes)
——- Trial 0 ——- Decision tree:
albuminS <= 36 (36.35): C (6)
albuminS >= 36.7 (36.35):
:...albuminAH >= 0.37 (0.334):
:...albuminS <= 39.3 (40.7): R (2)
: albuminS >= 42.1 (40.7): D (7/1)
albuminAH <= 0.298 (0.334):
:...IgGAH >= 0.034 (0.033):
:...IgGindex >= 0.919 (0.812): R (3)
: IgGindex <= 0.705 (0.812):
: :...IgGAH >= 0.044 (0.043): C (2)
: IgGAH <= 0.042 (0.043):
: :...IgGindex <= 0.504 (0.514): C (4/1)
: IgGindex >= 0.524 (0.514): R (6)
IgGAH <= 0.032 (0.033):
:...IFNgamaS >= 2.19 (2.105): R (3)
IFNgamaS <= 2.02 (2.105):
:...IFNgamaS >= 1.56 (1.525): D (3)
IFNgamaS <= 1.49 (1.525):
:...IFNgamaS >= 1.32 (1.25): C (2)
IFNgamaS <= 1.18 (1.25):
:...albuminS >= 44.9 (44.6):
:...albuminS <= 45 (45.35): C (2)
: albuminS >= 45.7 (45.35): R (3/1)
albuminS <= 42.7 (44.6):
:...IgGAH >= 0.023 (0.022): D (7/2)
IgGAH <= 0.021 (0.022):
:...IgGindex = N/A: N (5/2)
IgGindex <= 0.353 (0.402): R (4/1)
IgGindex >= 0.451 (0.402):
:...IgGindex >= 0.713 (0.661): D (2/1)
IgGindex <= 0.609 (0.661):
:...IgGindex <= 0.451 (0.488): D (3/1)
IgGindex >= 0.494 (0.488): C (4)
b. Evaluation on training data (68 cases):
Trial Decision Tree Rules
——- ———————— ————————
Size Errors No Errors
0 18 10(14.7%) 18 10(14.7%)
1 10 29(42.6%) 10 24(35.3%)
2 15 19(27.9%) 14 17(25.0%)
boost 6( 8.8%) 1( 1.5%) <<
(a) (b) (c) <-classified as
—— —— ——
23 (a): class C
1 19 (b): class D
25 (c): class R
Time: 0.1 secs
TABLE III (continued)
Total IgG in serum and aqueous humor were not significantly elevated
for any of the groups, although some patients had elevated rates. The latter
might be caused by intraocular IgG production, enhanced IgG filtration (lea-
kage) due to the barrier damage, or by their combination. Since the relative
concentration ratio (index) of transferred albumin and IgG on both sides of
the barrier defines the rate of aqueous humor IgG synthesis much better
than total aqueous IgG, we calculated and compared IgG indexes of all
groups.2–4,6,8
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c. Extracted rules 0/1–9:
Rule 0/1: (7, lift 2.4)
albuminS > 36
IgGAH > 0.032
IgGAH <= 0.042
IgGindex > 0.508
-> class R [0.889]
Rule 0/2: (6, lift 2.6)
albuminS <= 36
-> class C [0.875]
Rule 0/3: (7/1, lift 2.6)
albuminS > 40.5
albuminAH > 0.298
-> class D [0.778]
Rule 0/4: (7/2, lift 2.3)
IFNgamaS <= 1.18
albuminS > 36
albuminS <= 44.3
IgGAH > 0.022
IgGAH <= 0.032
-> class D [0.667]
Rule 0/5: (5, lift 2.5)
albuminS <= 44.3
IgGAH <= 0.022
IgGindex > 0.482
IgGindex <= 0.645
-> class C [0.857]
Rule 0/6: (3, lift 2.2)
IFNgamaS > 2.02
albuminAH <= 0.298
-> class R [0.800]
Rule 0/7: (3, lift 2.7)
IFNgamaS > 1.49
IFNgamaS <= 2.02
albuminAH <= 0.298
-> class D [0.800]
Rule 0/8: (5/2, lift 1.9)
IFNgamaS <= 1.18
albuminS <= 44.3
IgGindex = N/A
-> class D [0.571]
Rule 0/9: (5/1, lift 2.1)
albuminAH <= 0.298
IgGAH > 0.032
IgGindex <= 0.508
-> class C [0.714]
Extracted rules 0/10–18:
Rule 0/10: (4/1, lift 1.8)
IFNgamaS <= 1.49
albuminS > 36
IgGAH <= 0.022
IgGindex <= 0.402
-> class R [0.667]
Rule 0/11: (2, lift 2.2)
IFNgamaS > 1.18
IFNgamaS <= 1.49
-> class C [0.750]
Rule 0/12: (3/1, lift 1.6)
albuminS > 45
IgGAH <= 0.032
-> class R [0.600]
Rule 0/13: (3, lift 2.2)
IgGAH > 0.032
IgGindex > 0.786
-> class R [0.800]
Rule 0/14: (2, lift 2.0)
albuminS <= 40.5
albuminAH > 0.298
-> class R [0.750]
Rule 0/15: (2, lift 2.2)
albuminS > 44.3
albuminS <= 45
-> class C [0.750]
Rule 0/16: (3, lift 2.4)
albuminAH <= 0.298
IgGAH > 0.042
IgGindex <= 0.786
-> class C [0.800]
Rule 0/17: (4/1, lift 2.3)
IFNgamaS <= 2.02
albuminS > 36
IgGAH <= 0.032
IgGindex > 0.402
IgGindex <= 0.482
-> class D [0.667]
Rule 0/18: (3/1, lift 2.0)
IgGAH <= 0.032
IgGindex > 0.645
-> class D [0.600]
Default class: R
IgG indexes were elevated in type I diabetes with and without retino-
pathy. In type II diabetes, indexes were just above the borderline (Table II).
More pathology was found in the patients with type I diabetes and in re-
tinopathy. This confirmed the findings of other authors that the immune re-
sponse tends to be more pronounced in type I diabetes.17,18
The breakdown of blood aqueous-barrier in retinopathy may influence
the passage of systemic antibodies.1–4,6,8 However, we found only a few cases
with aqueous oligoclonal IgG (1 in type I and 2 in type II diabetes), while
much more IgG pathology was reflected by positive IgG indexes. This nega-
tive oligoclonal findings and positive IgG index values suggest a more pro-
nounced polyclonal intraocular IgG synthesis in diabetic patients.6 The de-
tected protein pattern is consistent with our previous results for type II dia-
betes.7
IFN- is a cytokine strongly involved in the breakdown of the ACAID
system.23–25 It was not detected in the aqueous humor of the control pa-
tients with senile cataract. This seems to suggest that IFN- is not directly
involved in senile cataract formation. Normal values of IgG indexes, low to-
tal aqueous IgG values and the absence of aqueous oligoclonal IgG seem to
exclude involvement of the IgG immune response in this type of cataract.1–8
Significant deviations of systemic IFN- were found in diabetes, espe-
cially in the type I disease.9–11 We measured hightened levels of this cyto-
kine in the aqueous humors and serums of type I disease, in contrast to the
senile cataract controls. This supports several experimental and clinical in-
vestigations linking IFN- (and related Th1 lymphocytes) to type I diabe-
tes.9–11
Machine learning program C5.0 extracted the decision rules that enable
a very accurate classification of 98.5% of subjects (Table IIIb) into the
groups of patients with senile cataract, diabetes without retinopathy and di-
abetes with retinopathy. One case misclassified to the control group had a
mild type II diabetes, which indicates that this insignificant error in the
classification occurred due to the less pronounced course of the disease. The
decision tree result was somewhat less precise, but still acceptable, 91.2% of
correct classifications.
The machine learning procedure presented in Table III does not discrim-
inate between different types of diabetes, which may be due to the insuffi-
cient selectivity and small number of immunochemical parameters measu-
red. The complexity of the decision tree and rules is also influenced by the
parameter specification.19 However, the decision rules may predict the onset
of retinal vascular complications, i.e. retinopathy, with almost 100% accu-
racy from only three serum and aqueous humor parameters (albumin, IgG
and IFN-). In this context, predictive values of albumin in serum and aque-
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ous humor may be related to the leakage of albumin through damaged ves-
sels. It is worth mentioning that C5.0 creates a supporting program that
performs the classification for each new case. Following addition of the new
case to the database, corrected trees and rules of enhanced precision are
generated.
Diabetic retinopathy is a severe and common complication of diabetes.
Extraction of algorithms for the accurate prediction of its onset, in different
types of the disease and from the serum parameters only, may be of great
prognostic and therapeutic value. Analyses of IgG subclasses, complement
components and other cytokines by means of machine learning20 or neural
network26 based methods might provide a better understanding and predic-
tion of the ocular immune-mediated processes in diabetes and retinopathy.
The procedure of data mining applied in this study may be useful ad-
junct to the standard immunochemical tests. Moreover, in the analysis of
the chemical information obtained from the parameters of the complex bio-
logical systems, artificial intelligence based analysis might be a prerequisite
for the extraction of implicit, previously unknown and potentially useful al-
gorithms describing the results. Significant savings in the laboratory mate-
rial and efforts may be obtained by means of the machine learning based op-
timization of the tests.
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SA@ETAK
Kvantifikacija intraokularnog interferona-
i IgG kod katarakte i dijabetesa
Josip Pavan, Nikola [tambuk, Biserka Pokri}, Pa{ko Konjevoda,
Milica Trbojevi}-^epe i Gordana Pavan
U radu je analizirana nova metoda interpretacije imunokemijskih testova zasno-
vana na umjetnoj inteligenciji. Odnosi albumina, IgG i interferona- dobiveni imuno-
kemijskim mjerenjima seruma i o~ne vodice, analizirani su strojnim klasifikatorom
C5.0 s obzirom na utjecaj i tip dijabetesa, o{te}enje mre`nice (retinopatiju) i propus-
nost krvno-o~ne barijere. Utvr|eno je da ispitanici s dijabetesom tipa I imaju pato-
lo{ke vrijednosti interferona- u o~noj vodici i serumu, te da je intraokularna sinteza
IgG u dijabetesu primarno poliklonska. Program C5.0 za strojno u~enje dao je algori-
tam pravila odlu~ivanja koji je uz 98.5% to~nosti razlu~io skupinu kontrolnih ispita-
nika sa stara~kom kataraktom od skupine s dijabetesom i dijabeti~kom retinopati-
jom. Programi strojnog u~enja mogu biti korisna dopuna analizi i interpretaciji imu-
nokemijskih pokazatelja standardnim statisti~kim metodama.
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